[1]
Robinson, E. Psychopharmacology: From serendipitous discoveries to rationale design, but what next? Brain Neurosci. Adv., 2018, 2, 2398212818812629. [Available from].
[http://dx.doi.org/10.1177/2398212818812629]
[http://dx.doi.org/10.1177/2398212818812629]
[2]
Telles-Correia, D. The mind-brain gap and the neuroscience-psychiatry gap. J. Eval. Clin. Pract., 2018, 24(4), 797-802. [Available from].
[http://dx.doi.org/10.1111/jep.12891]
[http://dx.doi.org/10.1111/jep.12891]
[3]
Castanheira, L.; Ferreira, M.F.; Sebastião, A.M.; Telles-Correia, D. Anxiety assessment in pre-clinical tests and in clinical trials: A critical re-view. Curr. Top. Med. Chem., 2018, 18(19), 1656-1676. [Available from].
[http://dx.doi.org/10.2174/1568026618666181115102518]
[http://dx.doi.org/10.2174/1568026618666181115102518]
[4]
Ferreira, M.F.; Castanheira, L.; Sebastião, A.M.; Telles-Correia, D. Depression assessment in clinical trials and pre-clinical tests: A critical review. Curr. Top. Med. Chem., 2018, 18(19), 1677-1703. [Available from].
[http://dx.doi.org/10.2174/1568026618666181115095920]
[http://dx.doi.org/10.2174/1568026618666181115095920]
[5]
Rema, J.; Novais, F.; Telles-Correia, D. Precision Psychiatry: Machine learning as a tool to find new pharmacological targets. Curr. Top. Med. Chem., 2022, 22(15), 1261-1269. [Available from].
[http://dx.doi.org/10.2174/1568026621666211004095917]
[http://dx.doi.org/10.2174/1568026621666211004095917]
[6]
Sousa, R.; Machado, R.J.; Novais, S. Psychedelics and hallucinogens in Psychiatry: finding new pharmacological targets. Curr. Top. Med. Chem., 2021, 22(15), 1250-1260.
[7]
Murillo-Rodríguez, E.; Carreón, C.; Acosta-Hernández, M.E.; García-García, F. Stimulants and Depressor Drugs in the Sleep-Wake Cycle Modulation: The case of alcohol and cannabinoids. Curr. Top. Med. Chem., 2022, 22(15), 1270-1279. [Available from].
[http://dx.doi.org/10.2174/1568026622666220105105054]
[http://dx.doi.org/10.2174/1568026622666220105105054]
[8]
Herrera-Morales, W.V.; Ramírez-Lugo, L.; Cauich-Kumul, R.; Murillo-Rodríguez, E.; Núñez-Jaramillo, L. Personalization of pharmacological treatments for ADHD: Why it is advisable and possible options to achieve it. Curr. Top. Med. Chem., 2022, 22(15), 1236-1249. [Available from].
[http://dx.doi.org/10.2174/1568026622666220509155413]
[http://dx.doi.org/10.2174/1568026622666220509155413]
[9]
Murillo-Rodríguez, E.; Coronado-Álvarez, A.; López-Muciño, L.A.; Pastrana-Trejo, J.C.; Viana-Torre, G.; Barberena, J.J. Neurobiology of dream activity and effects of stimulants on dreams. Curr. Top. Med. Chem., 2022, 22(15), 1280-1295. [Available from].
[http://dx.doi.org/10.2174/1568026622666220627162032]
[http://dx.doi.org/10.2174/1568026622666220627162032]